FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4353048118> ?p ?o ?g. }

• W4353048118 endingPage "821" @default.
• W4353048118 startingPage "808" @default.
• W4353048118 abstract "Catheter ablation improves ventricular tachycardia (VT) event-free (time to event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous myocardial infarction (MI). The effects of ablation on recurrent VT and implantable cardioverter-defibrillator (ICD) therapy (burden) have yet to be investigated.This study sought to compare the VT and ICD therapy burden following treatment with either ablation or escalated AAD therapy among patients with VT and previous MI in the VANISH (Ventricular tachycardia AblatioN versus escalated antiarrhythmic drug therapy in ISchemic Heart disease) trial.The VANISH trial randomized patients with previous MI and VT despite initial AAD therapy to either escalated AAD treatment or catheter ablation. VT burden was defined as the total number of VT events treated with ≥1 appropriate ICD therapy. Appropriate ICD therapy burden was defined as the total number of appropriate shocks or antitachycardia pacing therapies (ATPs) delivered. The Anderson-Gill recurrent event model was used to compare burden between the treatment arms.Of the 259 enrolled patients (median age, 69.8 years; 7.0% women), 132 patients were randomized to ablation and 129 patients were randomized to escalated AAD therapy. Over 23.4 months of follow-up, ablation-treated patients had a 40% lower shock-treated VT event burden and a 39% lower appropriate shock burden compared with patients who received escalated AAD therapy (P <0.05 for all). A reduction in VT burden, ATP-treated VT event burden, and appropriate ATP burden among ablation patients was only demonstrated in the stratum of patients with amiodarone-refractory VT (P <0.05 for all).Among patients with AAD-refractory VT and a previous MI, catheter ablation reduced shock-treated VT event burden and appropriate shock burden compared with escalated AAD therapy. There was also lower VT burden, ATP-treated VT event burden, and appropriate ATP burden among ablation-treated patients; however, the effect was limited to patients with amiodarone-refractory VT." @default.
• W4353048118 created "2023-03-23" @default.
• W4353048118 creator A5010703194 @default.
• W4353048118 creator A5016361708 @default.
• W4353048118 creator A5031577753 @default.
• W4353048118 creator A5039188388 @default.
• W4353048118 creator A5064130278 @default.
• W4353048118 creator A5068138290 @default.
• W4353048118 creator A5074045033 @default.
• W4353048118 creator A5074323600 @default.
• W4353048118 creator A5077573193 @default.
• W4353048118 creator A5088193599 @default.
• W4353048118 date "2023-06-01" @default.
• W4353048118 modified "2023-09-30" @default.
• W4353048118 title "Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy" @default.
• W4353048118 cites W1562812860 @default.
• W4353048118 cites W1965355671 @default.
• W4353048118 cites W1971352825 @default.
• W4353048118 cites W1985277411 @default.
• W4353048118 cites W1986705681 @default.
• W4353048118 cites W1986843348 @default.
• W4353048118 cites W2002864523 @default.
• W4353048118 cites W2008559341 @default.
• W4353048118 cites W2016807526 @default.
• W4353048118 cites W2033778430 @default.
• W4353048118 cites W2036033980 @default.
• W4353048118 cites W2075175982 @default.
• W4353048118 cites W2091984080 @default.
• W4353048118 cites W2108062940 @default.
• W4353048118 cites W2119818163 @default.
• W4353048118 cites W2126305797 @default.
• W4353048118 cites W2133521252 @default.
• W4353048118 cites W2139637015 @default.
• W4353048118 cites W2143923202 @default.
• W4353048118 cites W2152108583 @default.
• W4353048118 cites W2155544947 @default.
• W4353048118 cites W2165217958 @default.
• W4353048118 cites W2171402333 @default.
• W4353048118 cites W2220052445 @default.
• W4353048118 cites W2345572214 @default.
• W4353048118 cites W2407287461 @default.
• W4353048118 cites W2528468257 @default.
• W4353048118 cites W2595915933 @default.
• W4353048118 cites W2599761051 @default.
• W4353048118 cites W2607553825 @default.
• W4353048118 cites W2765936307 @default.
• W4353048118 cites W2782483490 @default.
• W4353048118 cites W2940793653 @default.
• W4353048118 cites W2944651207 @default.
• W4353048118 cites W3003338322 @default.
• W4353048118 cites W3035387930 @default.
• W4353048118 cites W3120879636 @default.
• W4353048118 cites W3163937374 @default.
• W4353048118 cites W4205591533 @default.
• W4353048118 cites W4225956500 @default.
• W4353048118 doi "https://doi.org/10.1016/j.jacep.2023.01.030" @default.
• W4353048118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37380314" @default.
• W4353048118 hasPublicationYear "2023" @default.
• W4353048118 type Work @default.
• W4353048118 citedByCount "0" @default.
• W4353048118 crossrefType "journal-article" @default.
• W4353048118 hasAuthorship W4353048118A5010703194 @default.
• W4353048118 hasAuthorship W4353048118A5016361708 @default.
• W4353048118 hasAuthorship W4353048118A5031577753 @default.
• W4353048118 hasAuthorship W4353048118A5039188388 @default.
• W4353048118 hasAuthorship W4353048118A5064130278 @default.
• W4353048118 hasAuthorship W4353048118A5068138290 @default.
• W4353048118 hasAuthorship W4353048118A5074045033 @default.
• W4353048118 hasAuthorship W4353048118A5074323600 @default.
• W4353048118 hasAuthorship W4353048118A5077573193 @default.
• W4353048118 hasAuthorship W4353048118A5088193599 @default.
• W4353048118 hasBestOaLocation W43530481181 @default.
• W4353048118 hasConcept C121332964 @default.
• W4353048118 hasConcept C126322002 @default.
• W4353048118 hasConcept C142424586 @default.
• W4353048118 hasConcept C164705383 @default.
• W4353048118 hasConcept C168563851 @default.
• W4353048118 hasConcept C2776131983 @default.
• W4353048118 hasConcept C2776331378 @default.
• W4353048118 hasConcept C2777093960 @default.
• W4353048118 hasConcept C2778094803 @default.
• W4353048118 hasConcept C2778902805 @default.
• W4353048118 hasConcept C2779161974 @default.
• W4353048118 hasConcept C500440147 @default.
• W4353048118 hasConcept C500558357 @default.
• W4353048118 hasConcept C71924100 @default.
• W4353048118 hasConcept C87355193 @default.
• W4353048118 hasConceptScore W4353048118C121332964 @default.
• W4353048118 hasConceptScore W4353048118C126322002 @default.
• W4353048118 hasConceptScore W4353048118C142424586 @default.
• W4353048118 hasConceptScore W4353048118C164705383 @default.
• W4353048118 hasConceptScore W4353048118C168563851 @default.
• W4353048118 hasConceptScore W4353048118C2776131983 @default.
• W4353048118 hasConceptScore W4353048118C2776331378 @default.
• W4353048118 hasConceptScore W4353048118C2777093960 @default.
• W4353048118 hasConceptScore W4353048118C2778094803 @default.
• W4353048118 hasConceptScore W4353048118C2778902805 @default.
• W4353048118 hasConceptScore W4353048118C2779161974 @default.

• next